SonderMind nabbed $150M for its tech that matches patients with low-cost mental health providers—below, we explore how startups like it are partnering up with competitors like Zocdoc to tap more customers.
The digital therapeutics company earned a first-of-its-kind FDA breakthrough designation for its BiovitalsHF heart failure DTx—we unpack how the FDA is opening up the opportunity for DTx vendors to take the same road.
Monitoring adhesives could stick out in the RPM market: Remote monitoring startup BioIntelliSense scored $45M for its vital monitoring stickers—here’s why less-frillywearable products like itcould carve a sticky spot in the ballooning remote patient monitoring market.
Telehealth stands stronger with DTx than alone: Amwell is acquiring digital mental health therapeutics company SilverCloud and automated virtual care firm Conversa Health, signalling a new chapter in telehealth.
Komodo grows into a healthcare analytics beast: The healthcare analytics company is acquiring drug pricing analytics firm Breakaway Partners—we unpack why this deal will turn Komodo into a healthcare analytics powerhouse.
Virtual mental healthcare is becoming need-to-have for digital health cos: D2C telehealth giant Ro is launching virtual mental health services—this marks yet another digital health co branching into the budding market opportunity in virtual mental healthcare.
Anthem, Humana JV could be a golden distro channel for DTx makers: The payers are developing a cloud-based pharmacy benefits management platform,—we unpack why its pricing transparency feature makes it a good choice for DTx vendors trying to get their therapies on drug formularies.